期刊文献+

基质金属蛋白酶MMP-9基质金属蛋白酶抑制剂TIMP-1与血管内皮生长因子在非小细胞肺癌侵袭转移过程中的关系研究 被引量:13

The Relationship of MMP-9、TIPM-1 and VEGF in the Invasion and Metastasis of Non-small-cell Lung Carcinoma
下载PDF
导出
摘要 目的:检测不同的非小细胞肺癌组织中MMP-9、TIMP-1及VEGF的表达情况,观察比较它们的表达特点,分析三种物质在非小细胞肺癌侵袭转移过程中的关系。方法:收集不同分化程度的原发性非小细胞肺癌患者手术标本60例。采用免疫组化SP法对其染色,光镜下分别观察以上不同组织中MMP-9、TIMP-1、VEGF的表达情况。结果:①在不同的与预后相关的病理指标中MMP-9/TIMP-1组合同时阴性表达与MMP-9/TIMP-1组合同时阳性表达结果有差异(P<0.05)。在不同的与预后相关的病理指标中MMP-9/VEGF组合同时阴性表达与MMP-9/VEGF组合同时阳性表达结果有差异(P<0.05)。在不同的与预后相关的病理指标中TIMP-1/VEGF组合同时阴性表达与TIMP-1/VEGF组合同时阳性表达结果有差异(P<0.05)。②三者之间的两两相关性检测显示MMP-9与VEGF、TIMP-1与VEGF在肺癌的表达结果具有相关性。结论:MMP-9与VEGF、TIMP-1与VEGF在肺癌的表达结果具有相关性。三者联合或两者联合检测比单纯依靠某一类指标所做的判断,将有更高的可靠性及参考价值。 Objective: To detect the expression of MMP-9、TIMP-1 and VEGF in patients with different non-small cell lung cancer,observe and compared their expression characteristics,analyze the relationship of the three substances in the invasion and metastasis of non-small-cell lung carcinoma.Method: We collected different degree of differentiation of non-small cell lung cancer specimens of 60 cases.Immunohistochemieal staining was employed to detect the expression of MMP-9 、TIMP-1 and VEGF in these cases.Result:①Both MMP-9 and TIMP-1 being negative expression and both MMP-9 and TIMP-1 being positive expression,which has statistically significance(P0.05) in different pathological prognostic indicators.Both MMP-9 and VEGF being negative expression and both MMP-9 and VEGF being positive expression,which has statistically significance(P0.05) in different pathological prognostic indicators.Both TIMP-1 and VEGF being negative expression and both TIMP-1 and VEGF being positive expression,which has statistically significance(P0.05) in different pathological prognostic indicators.②between the three pairwise correlation analysis showed that the expression of MMP-9 and VEGF、 TIMP-1 and VEGF have the relationships in lung cancer results.Conclusion:The expression of MMP-9、 TIMP-1 and VEGF have some relationships.The test result by three joint,or both than by an antibody will have higher reliability and reference values.
出处 《河北医学》 CAS 2011年第12期1563-1567,共5页 Hebei Medicine
关键词 基质金属蛋白酶 基质金属蛋白酶抑制因子 血管内皮生长因子 非小细胞肺癌 免疫组化 Matrix metalloproteinase Tissue inhibitors of matrix metalloproteinase Vascular endothelial growth factor Non-small cell lung cancer Immunohistochemistry
  • 相关文献

参考文献7

二级参考文献43

  • 1赵彤,朱梅刚,黄宗义,张亚历,张素娟,李梅芳.肺癌癌基因蛋白产物同步检测的对比分析[J].癌症,1995,14(1):13-15. 被引量:54
  • 2谷化平,冯和平,徐志勇,苏红.免疫组化在恶性黑色素瘤诊断中的作用[J].中国肿瘤临床,1996,23(8):599-600. 被引量:4
  • 3[1]Leung DW,Cachianes G,Kuang WJ,et al.Vascular endothelial growth factor is a secreted angiogenic mitognn.Science,1989,246(4935):1306-1309.
  • 4[2]Folkman J.What is the evidence that tumors are angingenesis dependent?J Natl Cancer Inst,1990,82(1):4-6.
  • 5[3]Weidner N,Folkman J,Pozza F.Tumor angiogenesis:a new significant and independent prognostic indicator in early-stage breast carcinoma.J Natl Cancer lnst,1992,84(24):1875-1887.
  • 6[4]Bicknell R,Harris AL.Novel growth regulatory factors and tumor angiogcnesis.Eur J Cancer,1991,27(6):781-785.
  • 7[5]Cox G,Jones JL,Andi A,et al.A biological staging model for operable non-small lung cancer.Thorax,2001,56(7):561-566.
  • 8[6]Aikawa H,Takahashi H,Fujimura S,et al.Immunohistoehemical study of tumor angiogenie factors in non-small cell lung cancer.Anticancer Res,1999,19(5B):4305-4309.
  • 9[7]Shou Y,Hirano T,Gong Y,et al.Influence of angiogenetic factors and matrix metalloproteinase upon tumor progression in non-small long cancer.Br J Cancer,2001,85(11):1706-1712.
  • 10[8]Adams J,Carder P J,Downey S,et al.Vascular endothelial growth factor(VEGF) in breast cancer:,comparison of plasma,serum,and tissue VEGF and microvessel density and effects of tamxifen.Cancer Res,2000,60(11):2898-2905.

共引文献1429

同被引文献97

引证文献13

二级引证文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部